company background image
IBXX.F logo

Imagion Biosystems OTCPK:IBXX.F Stock Report

Last Price

US$0.26

Market Cap

US$1.6m

7D

0%

1Y

n/a

Updated

06 Apr, 2024

Data

Company Financials

Imagion Biosystems Limited

OTCPK:IBXX.F Stock Report

Market Cap: US$1.6m

IBXX.F Stock Overview

Provides medical imaging technologies using magnetic resonance.

IBXX.F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Imagion Biosystems Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Imagion Biosystems
Historical stock prices
Current Share PriceAU$0.26
52 Week HighAU$1.87
52 Week LowAU$0.18
Beta1.89
11 Month Change0%
3 Month Changen/a
1 Year Changen/a
33 Year Change-95.73%
5 Year Changen/a
Change since IPO-89.33%

Recent News & Updates

Recent updates

Shareholder Returns

IBXX.FUS Medical EquipmentUS Market
7D0%1.1%1.5%
1Yn/a-2.8%22.8%

Return vs Industry: Insufficient data to determine how IBXX.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how IBXX.F performed against the US Market.

Price Volatility

Is IBXX.F's price volatile compared to industry and market?
IBXX.F volatility
IBXX.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.7%
Market Average Movement5.7%
10% most volatile stocks in US Market14.8%
10% least volatile stocks in US Market2.8%

Stable Share Price: IBXX.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine IBXX.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2016n/an/aimagionbiosystems.com

Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer.

Imagion Biosystems Limited Fundamentals Summary

How do Imagion Biosystems's earnings and revenue compare to its market cap?
IBXX.F fundamental statistics
Market capUS$1.59m
Earnings (TTM)-US$8.60m
Revenue (TTM)US$3.41m

0.5x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IBXX.F income statement (TTM)
RevenueAU$5.18m
Cost of RevenueAU$5.25m
Gross Profit-AU$71.27k
Other ExpensesAU$12.99m
Earnings-AU$13.07m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.40
Gross Margin-1.38%
Net Profit Margin-252.26%
Debt/Equity Ratio-75.8%

How did IBXX.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.